Veracyte Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Veracyte
VCYT Stock  USD 31.24  0.01  0.03%   
Veracyte financial statements provide useful quarterly and yearly information to potential Veracyte investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Veracyte financial statements helps investors assess Veracyte's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Veracyte's valuation are summarized below:
Gross Profit
309.7 M
Profit Margin
0.0542
Market Capitalization
2.4 B
Enterprise Value Revenue
4.9725
Revenue
445.8 M
There are currently one hundred twenty fundamental trend indicators for Veracyte that can be evaluated and compared over time across competition. All traders should double-check Veracyte's current fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 3.2 B in 2025. Enterprise Value is likely to gain to about 3 B in 2025

Veracyte Total Revenue

468.05 Million

Check Veracyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Veracyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 24.6 M, Interest Expense of 1.9 K or Selling General Administrative of 187.2 M, as well as many indicators such as Price To Sales Ratio of 13.72, Dividend Yield of 0.0 or PTB Ratio of 2.48. Veracyte financial statements analysis is a perfect complement when working with Veracyte Valuation or Volatility modules.
  
Check out the analysis of Veracyte Correlation against competitors.
For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

Veracyte Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.4 B1.3 B463.5 M
Slightly volatile
Other Current Liabilities63.9 M60.8 M20.9 M
Slightly volatile
Total Current Liabilities82.6 M78.6 M30 M
Slightly volatile
Total Stockholder Equity1.2 B1.2 B414.7 M
Slightly volatile
Other Liabilities5.6 M8.7 M5.2 M
Slightly volatile
Property Plant And Equipment Net74.7 M71.1 M20.4 M
Slightly volatile
Accounts Payable6.3 M8.6 M5.4 M
Slightly volatile
Cash128 M239.1 M110.3 M
Slightly volatile
Non Current Assets Total974.2 M927.8 M305.4 M
Slightly volatile
Other Assets1.091.151.6 M
Slightly volatile
Cash And Short Term Investments303.9 M289.4 M126 M
Slightly volatile
Net Receivables48.9 M46.5 M18.9 M
Slightly volatile
Common Stock Total Equity86.9 K82.8 K42.3 K
Slightly volatile
Common Stock Shares Outstanding44.9 M79.9 M39.4 M
Slightly volatile
Liabilities And Stockholders Equity1.4 B1.3 B463.5 M
Slightly volatile
Non Current Liabilities Total47.7 M45.4 M18.9 M
Slightly volatile
Inventory22.8 M21.8 M7.6 M
Slightly volatile
Other Current Assets15.3 M14.6 M5.6 M
Slightly volatile
Total Liabilities130.3 M124.1 M48.9 M
Slightly volatile
Property Plant And Equipment Gross116.1 M110.5 M27 M
Slightly volatile
Total Current Assets390.9 M372.3 M158.1 M
Slightly volatile
Common Stock46 K78 K39.5 K
Slightly volatile
Property Plant Equipment37.3 M35.5 M14.8 M
Slightly volatile
Short and Long Term Debt Total53.3 M50.7 M17.9 M
Slightly volatile
Net Tangible Assets458 M436.2 M175.3 M
Slightly volatile
Long Term Debt884.9 K931.5 K6.9 M
Pretty Stable
Long Term Debt Total884.9 K931.5 K6.9 M
Pretty Stable
Capital Surpluse1.8 B1.7 B682.6 M
Slightly volatile
Deferred Long Term Liabilities4.3 M5.2 M4.1 M
Slightly volatile
Short and Long Term Debt963.6 K1 M5.6 M
Slightly volatile
Short Term Debt7 M7.5 M7.7 M
Very volatile
Net Invested Capital1.2 B1.2 B362.2 M
Slightly volatile
Net Working Capital211.5 M293.6 M127.7 M
Slightly volatile
Capital Stock69.6 K78 K52.5 K
Slightly volatile
Non Current Liabilities Other923.4 K972 K13.7 M
Slightly volatile
Current Deferred Revenue1.8 M1.7 M1.1 M
Slightly volatile

Veracyte Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization24.6 M23.5 M9.7 M
Slightly volatile
Selling General Administrative187.2 M178.3 M56.9 M
Slightly volatile
Selling And Marketing Expenses40.1 M27.8 M34.6 M
Slightly volatile
Total Revenue468.1 M445.8 M149 M
Slightly volatile
Other Operating Expenses451.1 M429.6 M176.4 M
Slightly volatile
Research Development72.8 M69.3 M24.8 M
Slightly volatile
Cost Of Revenue155 M147.6 M51.3 M
Slightly volatile
Total Operating Expenses296.1 M282 M125.2 M
Slightly volatile
Interest Income11.7 M11.2 M2.7 M
Slightly volatile
Reconciled Depreciation16 M23.5 M9.9 M
Slightly volatile

Veracyte Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation38.1 M36.2 M13.2 M
Slightly volatile
Begin Period Cash Flow109.9 M217.3 M94.4 M
Slightly volatile
Depreciation24.6 M23.5 M9.4 M
Slightly volatile
Capital Expenditures11.9 M11.3 M4.5 M
Slightly volatile
End Period Cash Flow128.5 M240.6 M110.7 M
Slightly volatile
Change To Netincome33.3 M31.8 M12.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio13.726.894516.2167
Slightly volatile
PTB Ratio2.482.61348.1551
Slightly volatile
Days Sales Outstanding34.738.095642.1038
Slightly volatile
Book Value Per Share15.9115.15257.1276
Slightly volatile
Stock Based Compensation To Revenue0.110.08130.1103
Slightly volatile
Capex To Depreciation0.460.48110.8648
Slightly volatile
PB Ratio2.482.61348.1551
Slightly volatile
Inventory Turnover7.626.78717.1911
Pretty Stable
Days Of Inventory On Hand61.4853.778654.9255
Very volatile
Payables Turnover17.9517.09748.8617
Slightly volatile
Sales General And Administrative To Revenue0.570.39990.617
Slightly volatile
Research And Ddevelopement To Revenue0.150.15540.5055
Slightly volatile
Capex To Revenue0.02410.02530.0537
Slightly volatile
Cash Per Share3.833.72953.3204
Very volatile
Days Payables Outstanding20.2821.348361.2703
Slightly volatile
Intangibles To Total Assets0.680.65240.3059
Slightly volatile
Current Ratio4.94.73425.9478
Pretty Stable
Tangible Book Value Per Share2.554.22462.9897
Pretty Stable
Receivables Turnover11.089.581210.2274
Slightly volatile
Graham Number8.249.2710.1046
Slightly volatile
Shareholders Equity Per Share15.9115.15257.1276
Slightly volatile
Debt To Equity0.0410.04310.1376
Pretty Stable
Capex Per Share0.130.14540.1104
Very volatile
Graham Net Net1.982.72062.3135
Very volatile
Revenue Per Share6.035.74372.8705
Slightly volatile
Interest Debt Per Share0.560.65380.6513
Slightly volatile
Debt To Assets0.03710.0390.0853
Pretty Stable
Operating Cycle79.4291.874295.9818
Slightly volatile
Price Book Value Ratio2.482.61348.1551
Slightly volatile
Days Of Payables Outstanding20.2821.348361.2703
Slightly volatile
Ebt Per Ebit0.831.59481.0196
Very volatile
Company Equity Multiplier1.681.10551.5223
Slightly volatile
Long Term Debt To Capitalization0.00210.00220.091
Slightly volatile
Total Debt To Capitalization0.03930.04140.1041
Pretty Stable
Debt Equity Ratio0.0410.04310.1376
Pretty Stable
Quick Ratio4.874.45765.9095
Pretty Stable
Net Income Per E B T1.130.93761.1922
Slightly volatile
Cash Ratio4.033.04054.9086
Pretty Stable
Days Of Inventory Outstanding61.4853.778654.9255
Very volatile
Days Of Sales Outstanding34.738.095642.1038
Slightly volatile
Price To Book Ratio2.482.61348.1551
Slightly volatile
Fixed Asset Turnover5.696.26586.6716
Slightly volatile
Debt Ratio0.03710.0390.0853
Pretty Stable
Price Sales Ratio13.726.894516.2167
Slightly volatile
Asset Turnover0.510.34290.4544
Pretty Stable
Price Fair Value2.482.61348.1551
Slightly volatile

Veracyte Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.2 B3.1 B1.2 B
Slightly volatile
Enterprise Value3 B2.9 B1.1 B
Slightly volatile

Veracyte Fundamental Market Drivers

Forward Price Earnings25.8398
Cash And Short Term Investments289.4 M

Veracyte Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Veracyte Financial Statements

Veracyte shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Veracyte investors may analyze each financial statement separately, they are all interrelated. The changes in Veracyte's assets and liabilities, for example, are also reflected in the revenues and expenses on on Veracyte's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.7 M1.8 M
Total Revenue445.8 M468.1 M
Cost Of Revenue147.6 M155 M
Stock Based Compensation To Revenue 0.08  0.11 
Sales General And Administrative To Revenue 0.40  0.57 
Research And Ddevelopement To Revenue 0.16  0.15 
Capex To Revenue 0.03  0.02 
Revenue Per Share 5.74  6.03 
Ebit Per Revenue 0.04  0.04 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY